Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?”
Crossref DOI link: https://doi.org/10.1007/s10549-017-4114-y
Published Online: 2017-01-21
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
den Brok, Wendie D.
Speers, Caroline H.
Gondara, Lovedeep
Baxter, Emily
Tyldesley, Scott K.
Lohrisch, Caroline A.
License valid from 2017-01-21